July/August 2017 | Page 10

G ove r n men t Re lat ions HB 1553 has 29 cosponsors and is assigned to the House Health Committee. Sen. Judith Schwank introduced similar legislation, SB 678, in the Senate. Regulating Mail-Order Orthodontics Rep. Thomas Murt (R-Montgomery) introduced HB 412, legislation that would make it unlawful for dental technicians and dental labs operating in Pennsylvania to furnish orthodontic appliances unless a dentist has first examined the patient, authorized and prescribed the orthodontia services. This bill was introduced to stem a growing trend of technicians offering orthodontia treatment and/or appliances through the mail without patients having been seen by dentists, potentially jeopardizing patient safety by compromising their overall health. HB 412 has two cosponsors and is assigned to the House Professional Licensure Committee. Licensee Reporting Requirements and Suspensions Sen. Robert Tomlinson (R-Bucks) introduced SB 354, legislation that would require all licensees, registrants and certificate holders to report any disciplinary conduct by any licensing board or an arrest, indictment or conviction within 30 days. Failure to report would result in disciplinary action. SB 354 would also provide each licensing board and commission with authority to automatically suspend a licensee, under circumstances determined by the respective licensing board, to be an “immediate and clear danger to the public health and safety.” SB 354 passed the Senate in May and was referred to the House Professional Licensure Committee for consideration. Prohibiting Restrictive Covenants Not to Compete in Health Care Provider Employment Contracts According to Rep. DeLuca, the primary sponsor of HB 346, non-complete clauses in health care provider employment contracts “effectively limit a practitioners’ ability to find a new employer, switch employers, continue seeing patients and practicing in their community.” Supporters for this legislation believe that practitioners’ options are too limited, especially for young practitioners who have little option but to accept contracts’ restrictive terms. HB 346 has nine cosponsors and is assigned to the House Health Committee for first consideration. PDA leaders are taking all members’ concerns into consideration while formulating a position on this bill. 8 JU LY/AU GU ST 2017 | P EN N S YLVA N IA D EN TA L J O UR N A L Electronic Prescription for Controlled Substances Rep. Tedd Nesbit (R-Butler, Mercer) introduced HB 353, legislation that would require health care providers to use electronic prescriptions to prescribe controlled substances. There is an exemption for emergency situations. No prescription for a controlled substance in Schedule II could be refilled. For Schedule III or IV drugs no prescription could be filled or refilled more than six months after the date or be refilled more than five times after the date of the prescription, unless renewed by the provider. The prescription must be electronically transmitted to the pharmacy of choice. HB 353 has 22 cosponsors and was assigned to the House Health Committee for first consideration. It passed the House of Representatives in June and now resides in the Senate Health and Human Services Committee. Opioid Prescribing Guidelines Sen. Gene Yaw introduced SB 655, legislation requiring mandatory implementation of opioid prescribing guidelines developed by the state’s Safe and Effective Prescribing Practices Task Force. Convened by the Department of Health and the Department of Drug and Alcohol Programs, the task force developed and approved a number of guidelines for different provider groups, including: • Emergency Department Pain Treatment Guidelines: To appropriately relieve pain and attempt to identify those who may be abusing or addicted to opioid analgesics and refer them for special assistance. • Opioid Use and Safe Prescribing for Geriatric Pain: Highlights special problems concerning using opioids when treating older adults for chronic non-cancer pain. • Guidelines on the Use of Opioids to Treat Chronic Non-cancer Pain: These guidelines address the use of opioids for the treatment of chronic non-cancer pain. These guidelines do not address the use of opioids for acute pain, nor do they address the use of opioids for the treatment of pain at the end-of-life. • Guidelines on the Use of Opioids in a Dental Practice: These guidelines address the use of opioids for the treatment of acute dental pain. • Obstetrics and Gynecology Pain Treatment: This guideline addresses the use of opioids for the treatment of pain in pregnant patients, during and immediately following delivery, and during breastfeeding.